JP Morgan Chase’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-332,548
Closed -$12.4M – 5832
2018
Q1
$12.4M Buy
+332,548
New +$14M ﹤0.01% 1863

JP Morgan Chase's ARMO Position: Q2 2018 in Review

JP Morgan Chase sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 332,548 shares — an estimated $12.4M sold.

JP Morgan Chase first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $12.4M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

  • JP Morgan Chase reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • JP Morgan Chase sold 332,548 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $12.4M.
  • JP Morgan Chase first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • JP Morgan Chase's ARMO BioSciences, Inc. Common Stock position peaked at $12.4M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.